Welcome to our dedicated page for Rennova Health news (Ticker: RNVA), a resource for investors and traders seeking the latest updates and insights on Rennova Health stock.
Rennova Health, Inc. (RNVA) provides essential updates through this comprehensive news hub for investors and healthcare professionals. Track the latest developments in integrated medical solutions, regulatory compliance advancements, and operational improvements shaping modern healthcare delivery.
This resource consolidates official press releases and verified news about RNVA's innovative approaches to clinical support systems and revenue cycle management. Users gain immediate access to critical updates including strategic partnerships, technology implementations, and compliance milestones.
Discover updates across key operational areas: regulatory guidance developments, healthcare technology integrations, and patient care innovations. Each announcement reflects Rennova Health's commitment to creating interoperable systems that address complex industry challenges.
Bookmark this page for streamlined access to verified information about RNVA's progress in delivering unified healthcare solutions. Regular updates ensure stakeholders maintain current awareness of the company's initiatives in medical services optimization and compliance-driven operational frameworks.
Rennova Health, Inc. (OTC: RNVA) CEO Seamus Lagan discussed Q3 2022 performance in a recent Stock Day podcast, reporting estimated net revenues of over $4 million, marking a notable improvement compared to previous years. The Company is finalizing plans to launch a new behavioral health services initiative at its Big South Fork Hospital, starting with detox and residential care. Additionally, InnovaQor, Inc., which recently became a public company, plans to raise capital, with Rennova considering distributing some of its shares to shareholders.
Rennova Health, Inc. (OTC: RNVA) CEO Seamus Lagan discussed recent business updates and future plans on the Stock Day podcast. Notable improvements were reported in net revenues and hospital operations, with a confident outlook for profitability. The company plans to expand into behavioral health services, having hired an experienced director for this initiative. Lagan confirmed that approximately 10 billion shares are currently outstanding, with no plans for a reverse stock split. The management aims to stabilize operations while focusing on growth in behavioral health and potential acquisitions.
Rennova Health, Inc. (OTC: RNVA) CEO Seamus Lagan recently discussed the company's progression during an interview on Stock Day. The company has achieved a stabilized hospital operation, aided by a Critical Access Designation, with an optimistic forecast for cash flow positivity and profitability. Rennova is launching a mental and behavioral health division, Myrtle Recovery Centers, Inc., utilizing existing space, thus minimizing capital costs. The aim is to solidify a profitable model to support future expansions in rural healthcare.
Rennova Health, Inc. (OTC: RNVA) reported significant improvements in its 2021 financial results during a recent interview with CEO Seamus Lagan. The Company decreased its stockholder deficit by approximately $21 million and reduced losses from $17 million in 2020 to $5 million in 2021. Furthermore, assets increased from $12 million to $19 million, while liabilities were down by $14 million. Rennova's plans to expand its services into behavioral and mental health are set, aiming for a growth trajectory that could enhance future revenue.
Rennova Health, Inc. (OTC: RNVAD) announced a 1 for 10,000 reverse stock split, effective March 15, 2022. Following this action, the company's outstanding shares will decrease from approximately 44 billion to around 4.4 million. The split aims to consolidate shares without changing the par value of $0.0001. All outstanding preferred shares and stock options will also be adjusted accordingly. The reverse split was approved by directors on March 9, 2022, with majority shareholder consent received on December 15, 2021. The stock will trade under RNVAD for 20 days post-split.
Rennova Health, Inc. (OTC: RNVA) announced a 1 for 10,000 reverse stock split effective March 15, 2022. This consolidation will reduce the number of outstanding shares from approximately 44 billion to about 4.4 million, with fractional shares paid in cash. The nominal par value remains $0.0001. The move was approved by the company's directors and majority shareholders. Trading will commence on a post-split basis on March 16, 2022. Rennova operates healthcare facilities in rural areas, including an acute care hospital in Tennessee.
Rennova Health (OTC: RNVA) has received approval from the Centers for Medicare and Medicaid Services for its Scott County Community Hospital in Tennessee to be designated as a Critical Access Hospital (CAH), effective June 30, 2021. This designation allows the hospital to benefit from cost-based reimbursement from Medicare, potentially increasing revenue. The CAH status includes capital improvement costs in allowable Medicare reimbursement, aimed at improving financial performance and maintaining healthcare access in rural areas. CEO Seamus Lagan expressed optimism about the revenue boost for local services.
Rennova Health has executed a 1 for 1,000 reverse stock split effective July 16, 2021, reducing its outstanding shares from approximately 10 billion to 10 million. Starting July 19, trading will occur under the temporary symbol RNVAD, reverting to RNVA after 20 business days. The nominal par value remains unchanged at $0.0001. All stock options, warrants, and preferred shares will be adjusted accordingly. Stockholders will receive instructions for exchanging stock certificates from Computershare Inc., the appointed exchange agent.
Rennova Health, Inc. (OTC: RNVA, RNVAW) provided a business update during an interview with Stock Day host Everett Jolly. CEO Seamus Lagan reported stabilization in the company's operations during Q2, highlighting a significant reduction in convertible preference shares. The company anticipates filing its 10-Q by mid-August, aided by changes in the financial team. Lagan expressed confidence in the success of the newly separated software division and indicated an end to issuing additional common shares may be near. Long-term prospects appear promising despite pandemic-related challenges.
Rennova Health, Inc. (OTC: RNVA; RNVAW) announced a 1 for 1,000 reverse stock split effective at 5:00 PM ET on July 16, 2021. The post-split trading will commence on July 19, 2021, reducing outstanding shares from approximately 10 billion to 10 million. Preferred shares, stock options, and warrants will also be adjusted accordingly. This move follows approval by the company's directors on July 8, 2021, and aims to consolidate share structure without altering the par value per share. The split is expected to better position the company in the market.
